Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,096 JPY | -0.41% | -0.92% | +1.04% |
16/05 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
15/05 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.04% | 40.96B | |
+39.22% | 731B | |
+32.14% | 586B | |
-7.85% | 348B | |
+15.48% | 319B | |
-0.12% | 273B | |
+13.32% | 235B | |
+7.42% | 202B | |
-7.12% | 203B | |
-3.37% | 158B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Transcript : Takeda Pharmaceutical Company Limited, Q4 2022 Earnings Call, May 11, 2022